Ackerman, M. E., B. Moldt, R. T. Wyatt, A. S. Dugast, E. McAndrew, S. Tsoukas, S. Jost, C. T. Berger, G. Sciaranghella, Q. Liu, D. J. Irvine, D. R. Burton and G. Alter (2011). "A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples." J Immunol Methods 366(1-2): 8-19.

               

Addo, M. M., M. Altfeld, D. M. Brainard, A. Rathod, A. Piechocka-Trocha, U. Fideli, J. Mulenga, E. Shutes, D. M. Alvino, E. Hunter, S. A. Allen and B. D. Walker (2011). "Lack of detectable HIV-1-specific CD8(+) T cell responses in Zambian HIV-1-exposed seronegative partners of HIV-1-positive individuals." J Infect Dis 203(2): 258-262.

               

Agrawal, N., D. P. Leaman, E. Rowcliffe, H. Kinkead, R. Nohria, J. Akagi, K. Bauer, S. X. Du, R. G. Whalen, D. R. Burton and M. B. Zwick (2011). "Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1)." PLoS ONE 6(6): e21339.

               

Agrawal-Gamse, C., R. J. Luallen, B. Liu, H. Fu, F. H. Lee, Y. Geng and R. W. Doms (2011). "Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans." J Virol 85(1): 470-480.

               

Allen, S. A., E. Chomba, E. Karita, W. Kilembe, M. Inambao and G. Streeb (2011). "The contribution of HIV-discordant relationships to new HIV infections: a rebuttal." Aids 25(10): 1341-1343; author reply 1343-1344.

               

Asiki, G., J. Mpendo, A. Abaasa, C. Agaba, A. Nanvubya, L. Nielsen, J. Seeley, P. Kaleebu, H. Grosskurth and A. Kamali (2011). "HIV and syphilis prevalence and associated risk factors among fishing communities of Lake Victoria, Uganda." Sex Transm Infect 87(6): 511-515.

Azoitei, M. L., B. E. Correia, Y. E. Ban, C. Carrico, O. Kalyuzhniy, L. Chen, A. Schroeter, P. S. Huang, J. S. McLellan, P. D. Kwong, D. Baker, R. K. Strong and W. R. Schief (2011). "Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold." Science 334(6054): 373-376.

Baeten, J. M., E. Kahle, J. R. Lingappa, R. W. Coombs, S. Delany-Moretlwe, E. Nakku-Joloba, N. R. Mugo, A. Wald, L. Corey, D. Donnell, M. S. Campbell, J. I. Mullins, C. Celum and H. S. V. H. I. V. T. S. T. Partners in Prevention (2011). "Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission." Sci Transl Med 3(77): 77ra29.

               

Barouch, D. H., S. V. Kik, G. J. Weverling, R. Dilan, S. L. King, L. F. Maxfield, S. Clark, D. Ng'ang'a, K. L. Brandariz, P. Abbink, F. Sinangil, G. de Bruyn, G. E. Gray, S. Roux, L. G. Bekker, A. Dilraj, H. Kibuuka, M. L. Robb, N. L. Michael, O. Anzala, P. N. Amornkul, J. Gilmour, J. Hural, S. P. Buchbinder, M. S. Seaman, R. Dolin, L. R. Baden, A. Carville, K. G. Mansfield, M. G. Pau and J. Goudsmit (2011). "International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations." Vaccine 29(32): 5203-5209.

               

Berkley, S. (2011). "Straight talk with...Seth Berkley by Khamsi Roxanne." Nat Med 17(4): 404.

               

Berkley, S. (2011). "A passion for global vaccines." Hum Vaccin 7(6): 600-603.

               

Boeras, D. I., P. T. Hraber, M. Hurlston, T. Evans-Strickfaden, T. Bhattacharya, E. E. Giorgi, J. Mulenga, E. Karita, B. T. Korber, S. Allen, C. E. Hart, C. A. Derdeyn and E. Hunter (2011). "Role of donor genital tract HIV-1 diversity in the transmission bottleneck." Proc Natl Acad Sci U S A 108(46): E1156-1163.

               

Boeras, D. I., N. Luisi, E. Karita, S. McKinney, T. Sharkey, M. Keeling, E. Chomba, C. Kraft, K. Wall, J. Bizimana, W. Kilembe, A. Tichacek, A. M. Caliendo, E. Hunter and S. Allen (2011). "Indeterminate and discrepant rapid HIV test results in couples' HIV testing and counselling centres in Africa." J Int AIDS Soc 14: 18.

               

Bonomelli, C., K. J. Doores, D. C. Dunlop, V. Thaney, R. A. Dwek, D. R. Burton, M. Crispin and C. N. Scanlan (2011). "The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade." PLoS ONE 6(8): e23521.

               

Burton, D. R., A. J. Hessell, B. F. Keele, P. J. Klasse, T. A. Ketas, B. Moldt, D. C. Dunlop, P. Poignard, L. A. Doyle, L. Cavacini, R. S. Veazey and J. P. Moore (2011). "Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody." Proc Natl Acad Sci U S A 108(27): 11181-11186.

               

Campbell, M. S., J. I. Mullins, J. P. Hughes, C. Celum, K. G. Wong, D. N. Raugi, S. Sorensen, J. N. Stoddard, H. Zhao, W. Deng, E. Kahle, D. Panteleeff, J. M. Baeten, F. E. McCutchan, J. Albert, T. Leitner, A. Wald, L. Corey, J. R. Lingappa and H. S. V. H. I. V. T. S. T. Partners in Prevention (2011). "Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial." PLoS ONE 6(3): e16986.

               

Chakrabarti, B. K., M. Pancera, S. Phogat, S. O'Dell, K. McKee, J. Guenaga, J. Robinson, J. Mascola and R. T. Wyatt (2011). "HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies." AIDS Res Hum Retroviruses 27(8): 877-887.

               

Chakrabarti, B. K., L. M. Walker, J. F. Guenaga, A. Ghobbeh, P. Poignard, D. R. Burton and R. T. Wyatt (2011). "Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity." J Virol 85(16): 8217-8226.

               

Changela, A., X. Wu, Y. Yang, B. Zhang, J. Zhu, G. A. Nardone, S. O'Dell, M. Pancera, M. K. Gorny, S. Phogat, J. E. Robinson, L. Stamatatos, S. Zolla-Pazner, J. R. Mascola and P. D. Kwong (2011). "Crystal structure of human antibody 2909 reveals conserved features of quaternary structure-specific antibodies that potently neutralize HIV-1." J Virol 85(6): 2524-2535.

               

Crawford, H., P. C. Matthews, M. Schaefer, J. M. Carlson, A. Leslie, W. Kilembe, S. Allen, T. Ndung'u, D. Heckerman, E. Hunter and P. J. Goulder (2011). "The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8+ T-cell escape mutations and covarying HLA-independent polymorphisms." J Virol 85(3): 1384-1390.

               

Dolter, K. E., C. F. Evans, B. Ellefsen, J. Song, M. Boente-Carrera, R. Vittorino, T. J. Rosenberg, D. Hannaman and S. Vasan (2011). "Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation." Vaccine 29(4): 795-803.

               

Du, S. X., L. Xu, W. Zhang, S. Tang, R. I. Boenig, H. Chen, E. B. Mariano, M. B. Zwick, P. W. Parren, D. R. Burton, T. Wrin, C. J. Petropoulos, J. A. Ballantyne, M. Chambers and R. G. Whalen (2011). "A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein." PLoS ONE 6(6): e20927.

               

Duncan, S., A. N. Thiong'o, M. Macharia, L. Wamuyu, S. Mwarumba, B. Mvera, A. D. Smith, S. Morpeth, S. M. Graham and E. J. Sanders (2011). "High prevalence of quinolone resistance in Neisseria gonorrhoeae in coastal Kenya." Sex Transm Infect 87(3): 231.

               

El-Sadr, W., B. Coburn and S. Blower (2011). "Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission." AIDS 25: 2295 - 2299.

               

Euler, Z., E. M. Bunnik, J. A. Burger, B. D. Boeser-Nunnink, M. L. Grijsen, J. M. Prins and H. Schuitemaker (2011). "Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic." J Virol 85(14): 7236-7245.

               

Excler, J. L., W. Rida, F. Priddy, J. Gilmour, A. B. McDermott, A. Kamali, O. Anzala, G. Mutua, E. J. Sanders, W. Koff, S. Berkley and P. Fast (2011). "AIDS vaccines and preexposure prophylaxis: is synergy possible?" AIDS Res Hum Retroviruses 27(6): 669-680.

               

Graham, S. M., J. N. Krieger, P. L. Githua, L. W. Wamuyu, S. Wale, K. M. Ramko, J. A. Dragavon, C. H. Muller, S. E. Holte, K. N. Mandaliya, R. S. McClelland, N. M. Peshu, E. J. Sanders and R. W. Coombs (2011). "Post-prostatic massage fluid/urine as an alternative to semen for studying male genitourinary HIV-1 shedding." Sex Transm Infect 87(3): 232-237.

               

Gray, G., M. Allen, Z. Moodie, G. Churchyard, L. Bekker, M. Nchabeleng, K. Mlisana, B. Metch, B. de, M. Latka, S. Roux, M. Mathebula, N. Naicker, C. Ducar, D. Carter, A. Puren, N. Eaton, M. McElrath, M. Robertson, L. Corey and J. Kublin (2011). "Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study." Lancet Infect Dis 11: 507 - 515.

               

Hansen, S. G., J. C. Ford, M. S. Lewis, A. B. Ventura, C. M. Hughes, L. Coyne-Johnson, N. Whizin, K. Oswald, R. Shoemaker, T. Swanson, A. W. Legasse, M. J. Chiuchiolo, C. L. Parks, M. K. Axthelm, J. A. Nelson, M. A. Jarvis, M. Piatak, Jr., J. D. Lifson and L. J. Picker (2011). "Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine." Nature 473(7348): 523-527.

               

Hara, H., H. Hara, T. Hironaka, M. Inoue, A. Iida, T. Shu, M. Hasegawa, Y. Nagai, A. R. Falsey, A. Kamali, O. Anzala, E. J. Sanders, E. Karita, L. Mwananyanda, S. Vasan, A. Lombardo, C. L. Parks, E. Sayeed, M. Krebs, E. Cormier, J. Ackland, M. A. Price and J. L. Excler (2011). "Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors." Hum Vaccin 7(6): 639-645.

               

Harris, A., M. J. Borgnia, D. Shi, A. Bartesaghi, H. He, R. Pejchal, Y. K. Kang, R. Depetris, A. J. Marozsan, R. W. Sanders, P. J. Klasse, J. L. Milne, I. A. Wilson, W. C. Olson, J. P. Moore and S. Subramaniam (2011). "Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures." Proc Natl Acad Sci U S A 108(28): 11440-11445.

               

Harvey, D. J., F. Sobott, M. Crispin, A. Wrobel, C. Bonomelli, S. Vasiljevic, C. N. Scanlan, C. A. Scarff, K. Thalassinos and J. H. Scrivens (2011). "Ion mobility mass spectrometry for extracting spectra of N-glycans directly from incubation mixtures following glycan release: application to glycans from engineered glycoforms of intact, folded HIV gp120." J Am Soc Mass Spectrom 22(3): 568-581.

               

Kaltsidis, H., H. Cheeseman, J. Kopycinski, A. Ashraf, M. C. Cox, L. Clark, I. Anjarwalla, L. Dally, P. Bergin, A. Spentzou, C. Higgs, F. Gotch, B. Gazzard, R. Gomez, P. Hayes, P. Kelleher, D. K. Gill and J. Gilmour (2011). "Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials." J Immunol Methods 370(1-2): 43-54.

               

Kar, A. K., Y. Mao, G. Bird, L. Walensky and J. Sodroski (2011). "Characterization of a core fragment of the rhesus monkey TRIM5alpha protein." BMC Biochem 12(1): 1.

               

Kelley, A. L., E. Karita, P. S. Sullivan, F. Katangulia, E. Chomba, M. Carael, J. Telfair, S. M. Dunham, C. M. Vwalika, M. G. Kautzman, K. M. Wall and S. A. Allen (2011). "Knowledge and perceptions of couples' voluntary counseling and testing in urban Rwanda and Zambia: a cross-sectional household survey." PLoS ONE 6(5): e19573.

               

Kim, A., T. Hallett, J. Stover, E. Gouws, J. Musinguzi, P. Mureithi, R. Bunnell, J. Hargrove, J. Mermin, R. Kaiser, A. Barsigo and P. Ghys (2011). "Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods." PLoS One 6: e17535.

               

Kim, J., C. Tipper and J. Sodroski (2011). "Role of TRIM5alpha RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus." J Virol 85(16): 8116-8132.

               

Lambdin, B. H., W. Kanweka, M. Inambao, L. Mwananyanda, H. D. Shah, S. Linton, F. Wong, N. Luisi, A. Tichacek, J. Kalowa, E. Chomba and S. Allen (2011). "Local residents trained as 'influence agents' most effective in persuading African couples on HIV counseling and testing." Health Aff (Millwood) 30(8): 1488-1497.

               

Langedijk, J. P., M. J. Zekveld, M. Ruiter, D. Corti and J. W. Back (2011). "Helical peptide arrays for lead identification and interaction site mapping." Anal Biochem 417(1): 149-155.

               

Lau, C. Y., E. M. Swann and S. Singh (2011). "Behavioral and social science in HIV vaccine clinical research: Workshop report." Vaccine 29(14): 2509-2514.

               

Li, X., D. F. Yeung, A. M. Fiegen and J. Sodroski (2011). "Determinants of the higher order association of the restriction factor TRIM5alpha and other tripartite motif (TRIM) proteins." J Biol Chem 286(32): 27959-27970.

               

Li, Y., S. O'Dell, L. M. Walker, X. Wu, J. Guenaga, Y. Feng, S. D. Schmidt, K. McKee, M. K. Louder, J. E. Ledgerwood, B. S. Graham, B. F. Haynes, D. R. Burton, R. T. Wyatt and J. R. Mascola (2011). "Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01." J Virol 85(17): 8954-8967.

               

Liang, C. H., S. K. Wang, C. W. Lin, C. C. Wang, C. H. Wong and C. Y. Wu (2011). "Effects of neighboring glycans on antibody-carbohydrate interaction." Angew Chem Int Ed Engl 50(7): 1608-1612.

               

Lynch, R. M., R. Rong, S. Boliar, A. Sethi, B. Li, J. Mulenga, S. Allen, J. E. Robinson, S. Gnanakaran and C. A. Derdeyn (2011). "The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter." J Virol 85(2): 905-915.

               

Malhotra, R., L. Hu, W. Song, I. Brill, J. Mulenga, S. Allen, E. Hunter, S. Shrestha, J. Tang and R. A. Kaslow (2011). "Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians." Retrovirology 8: 22.

               

McLellan, J. S., M. Pancera, C. Carrico, J. Gorman, J. P. Julien, R. Khayat, R. Louder, R. Pejchal, M. Sastry, K. Dai, S. O'Dell, N. Patel, S. Shahzad-ul-Hussan, Y. Yang, B. Zhang, T. Zhou, J. Zhu, J. C. Boyington, G. Y. Chuang, D. Diwanji, I. Georgiev, Y. D. Kwon, D. Lee, M. K. Louder, S. Moquin, S. D. Schmidt, Z. Y. Yang, M. Bonsignori, J. A. Crump, S. H. Kapiga, N. E. Sam, B. F. Haynes, D. R. Burton, W. C. Koff, L. M. Walker, S. Phogat, R. Wyatt, J. Orwenyo, L. X. Wang, J. Arthos, C. A. Bewley, J. R. Mascola, G. J. Nabel, W. R. Schief, A. B. Ward, I. A. Wilson and P. D. Kwong (2011). "Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9." Nature 480(7377): 336-343.

               

Merino, A., R. Malhotra, M. Morton, J. Mulenga, S. Allen, E. Hunter, J. Tang and R. A. Kaslow (2011). "Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples." J Infect Dis 203(4): 487-495.

               

Merino, A., R. Malhotra, M. Morton, J. Mulenga, S. Allen, E. Hunter, J. Tang and R. A. Kaslow (2011). "Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples." J Infect Dis 203(4): 487-495.

               

Moldt, B., N. Schultz, D. C. Dunlop, M. D. Alpert, J. D. Harvey, D. T. Evans, P. Poignard, A. J. Hessell and D. R. Burton (2011). "A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcgamma receptors to define the role of effector functions in protection against HIV." J Virol 85(20): 10572-10581.

               

Mugo, N. R., R. Heffron, D. Donnell, A. Wald, E. O. Were, H. Rees, C. Celum, J. N. Kiarie, C. R. Cohen, K. Kayintekore, J. M. Baeten and H. S. V. H. I. V. T. S. T. Partners in Prevention (2011). "Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples." Aids 25(15): 1887-1895.

               

Mujugira, A., R. A. Morrow, C. Celum, J. Lingappa, S. Delany-Moretlwe, K. H. Fife, R. Heffron, G. De Bruyn, B. Homawoo, E. Karita, N. Mugo, B. Vwalika, J. M. Baeten and H. S. V. H. I. V. T. S. T. Partners in Prevention (2011). "Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries." Sex Transm Infect 87(3): 238-241.

               

Nicolaou, K. C., S. Sanchini, D. Sarlah, G. Lu, T. R. Wu, D. K. Nomura, B. F. Cravatt, B. Cubitt, J. C. de la Torre, A. J. Hessell and D. R. Burton (2011). "Organic Synthesis Toward Small-Molecule Probes and Drugs Special Feature: Design, synthesis, and biological evaluation of a biyouyanagin compound library." Proc Natl Acad Sci U S A 108(17): 6715-6720.

               

Njai, H. F., B. Gombe, T. Khamis, J. Birungi, E. Ruzagira, D. Admassu, T. Tarragona-Fiol, K. Porter, G. Stevens, J. Mugisha, J. Gilmour, A. Kamali and P. Kaleebu (2011). "Setting Up a Standardized Peripheral Blood Mononuclear Cells Processing Laboratory to Support Multi-center HIV/AIDS Vaccine and Intervention Trials." Laboratory Medicine 42(12): 711-718.

               

Nyblade, L., S. Singh, K. Ashburn, L. Brady and J. Olenja (2011). "Once I begin to participate, people will run away from me”: Understanding stigma as a barrier to HIV vaccine research participation in Kenya." Vaccine 29(48): 8924-8928.

               

Nyiro, J. U., E. J. Sanders, C. Ngetsa, S. Wale, K. Awuondo, E. Bukusi, M. A. Price, P. N. Amornkul and D. J. Nokes (2011). "Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya." BMC Infect Dis 11: 155.

Okuku, H. S., E. J. Sanders, J. Nyiro, C. Ngetsa, E. Ohuma, R. S. McClelland, M. A. Price and S. M. Graham (2011). "Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior." Sex Transm Dis 38(9): 837-844.

               

Omosa-Manyonyi, G. S., W. Jaoko, O. Anzala, H. Ogutu, S. Wakasiaka, R. Malogo, J. Nyange, P. Njuguna, J. Ndinya-Achola, K. Bhatt, B. Farah, M. Oyaro, C. Schmidt, F. Priddy and P. Fast (2011). "Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya." PLoS ONE 6(1): e14580.

               

Papo, J. K., E. K. Bauni, E. J. Sanders, P. Brocklehurst and H. W. Jaffe (2011). "Exploring the condom gap: is supply or demand the limiting factor - condom access and use in an urban and a rural setting in Kilifi district, Kenya." Aids 25(2): 247-255.

               

Pejchal, R., K. J. Doores, L. M. Walker, R. Khayat, P. S. Huang, S. K. Wang, R. L. Stanfield, J. P. Julien, A. Ramos, M. Crispin, R. Depetris, U. Katpally, A. Marozsan, A. Cupo, S. Maloveste, Y. Liu, R. McBride, Y. Ito, R. W. Sanders, C. Ogohara, J. C. Paulson, T. Feizi, C. N. Scanlan, C. H. Wong, J. P. Moore, W. C. Olson, A. B. Ward, P. Poignard, W. R. Schief, D. R. Burton and I. A. Wilson (2011). "A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield." Science 334(6059): 1097-1103.

               

Price, M. A., C. L. Wallis, S. Lakhi, E. Karita, A. Kamali, O. Anzala, E. J. Sanders, L. G. Bekker, R. Twesigye, E. Hunter, P. Kaleebu, K. Kayitenkore, S. Allen, E. Ruzagira, M. Mwangome, G. Mutua, P. N. Amornkul, G. Stevens, S. L. Pond, M. Schaefer, M. A. Papathanasopoulos, W. Stevens, J. Gilmour and I. E. I. C. S. Group (2011). "Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa." AIDS Res Hum Retroviruses 27(1): 5-12.

               

Reynolds, M. R., J. B. Sacha, A. M. Weiler, G. J. Borchardt, C. E. Glidden, N. C. Sheppard, F. A. Norante, P. A. Castrovinci, J. J. Harris, H. T. Robertson, T. C. Friedrich, A. B. McDermott, N. A. Wilson, D. B. Allison, W. C. Koff, W. E. Johnson and D. I. Watkins (2011). "The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge." J Virol 85(18): 9637-9640.

               

Ringe, R., D. Sharma, S. Zolla-Pazner, S. Phogat, A. Risbud, M. Thakar, R. Paranjape and J. Bhattacharya (2011). "A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop." Virology 418(2): 123-132.

               

Ruzagira, E., S. Wandiembe, A. Abaasa, A. N. Bwanika, U. Bahemuka, P. Amornkul, M. A. Price, H. Grosskurth and A. Kamali (2011). "HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study." PLoS ONE 6(8): e24037.

               

.

               

Ruzagira, E., S. Wandiembe, A. Abaasa, J. Levin, A. Bwanika, U. Bahemuka, M. A. Price and A. Kamali (2011). "Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda." PLoS ONE 6(6): e20684.

               

Sanders, E. J., E. Wahome, M. Mwangome, A. N. Thiong'o, H. S. Okuku, M. A. Price, L. Wamuyu, M. Macharia, R. S. McClelland and S. M. Graham (2011). "Most adults seek urgent healthcare when acquiring HIV-1 and are frequently treated for malaria in coastal Kenya." Aids 25(9): 1219-1224.

               

Scheid, J. F., H. Mouquet, B. Ueberheide, R. Diskin, F. Klein, T. Y. Oliveira, J. Pietzsch, D. Fenyo, A. Abadir, K. Velinzon, A. Hurley, S. Myung, F. Boulad, P. Poignard, D. R. Burton, F. Pereyra, D. D. Ho, B. D. Walker, M. S. Seaman, P. J. Bjorkman, B. T. Chait and M. C. Nussenzweig (2011). "Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding." Science 333(6049): 1633-1637.

               

Song, W., D. He, I. Brill, R. Malhotra, J. Mulenga, S. Allen, E. Hunter, J. Tang and R. A. Kaslow (2011). "Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population." PLoS ONE 6(8): e23469.

               

Stanfield, R. L., J.-P. Julien, R. Pejchal, J. S. Gach, M. B. Zwick and I. A. Wilson (2011). "Structure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing Epitope." Journal of Molecular Biology 414(3): 460-476.

               

Stansell, E., K. Canis, S. M. Haslam, A. Dell and R. C. Desrosiers (2011). "Simian immunodeficiency virus from the sooty mangabey and rhesus macaque is modified with O-linked carbohydrate." J Virol 85(1): 582-595.

               

Stephenson, R., B. Vwalika, L. Greenberg, Y. Ahmed, C. Vwalika, E. Chomba, W. Kilembe, A. Tichacek and S. Allen (2011). "A randomized controlled trial to promote long-term contraceptive use among HIV-serodiscordant and concordant positive couples in Zambia." J Womens Health (Larchmt) 20(4): 567-574.

               

Talati, N. J., E. Gonzalez-Diaz, C. Mutemba, J. Wendt, W. Kilembe, L. Mwananyanda, E. Chomba, S. Allen, C. del Rio and H. M. Blumberg (2011). "Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays." BMC Infect Dis 11: 264.

               

Tang, J., E. Cormier, J. Gilmour, M. A. Price, H. A. Prentice, W. Song, A. Kamali, E. Karita, S. Lakhi, E. J. Sanders, O. Anzala, P. N. Amornkul, S. Allen, E. Hunter, R. A. Kaslow and I. A. H. R. Network (2011). "Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes." J Virol 85(17): 8894-8902.

               

van Montfort, T., M. Melchers, G. Isik, S. Menis, P. S. Huang, K. Matthews, E. Michael, B. Berkhout, W. R. Schief, J. P. Moore and R. W. Sanders (2011). "A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responses." J Biol Chem 286(25): 22250-22261.

               

Vasan, S., A. Hurley, S. J. Schlesinger, D. Hannaman, D. F. Gardiner, D. P. Dugin, M. Boente-Carrera, R. Vittorino, M. Caskey, J. Andersen, Y. Huang, J. H. Cox, T. Tarragona-Fiol, D. K. Gill, H. Cheeseman, L. Clark, L. Dally, C. Smith, C. Schmidt, H. H. Park, J. T. Kopycinski, J. Gilmour, P. Fast, R. Bernard and D. D. Ho (2011). "In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers." PLoS ONE 6(5): e19252.

               

Vojnov, L., A. T. Bean, E. J. Peterson, M. J. Chiuchiolo, J. B. Sacha, F. S. Denes, M. Sandor, D. H. Fuller, J. T. Fuller, C. L. Parks, A. B. McDermott, N. A. Wilson and D. I. Watkins (2011). "DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4(+) T cells, but few subdominant epitope-specific CD8(+) T cells." Vaccine 29(43): 7483-7490.

               

Walker, L. M., M. Huber, K. J. Doores, E. Falkowska, R. Pejchal, J. P. Julien, S. K. Wang, A. Ramos, P. Y. Chan-Hui, M. Moyle, J. L. Mitcham, P. W. Hammond, O. A. Olsen, P. Phung, S. Fling, C. H. Wong, S. Phogat, T. Wrin, M. D. Simek, G. P. I. Protocol, W. C. Koff, I. A. Wilson, D. R. Burton and P. Poignard (2011). "Broad neutralization coverage of HIV by multiple highly potent antibodies." Nature 477(7365): 466-470.

               

Walker, L. M., D. Sok, Y. Nishimura, O. Donau, R. Sadjadpour, R. Gautam, M. Shingai, R. Pejchal, A. Ramos, M. D. Simek, Y. Geng, I. A. Wilson, P. Poignard, M. A. Martin and D. R. Burton (2011). "Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque." Proc Natl Acad Sci U S A 108(50): 20125-20129.

               

Weinfurter, J. T., G. E. May, T. Soma, A. J. Hessell, E. J. Leon, C. E. Macnair, S. M. Piaskowski, K. Weisgrau, J. Furlott, N. J. Maness, J. Reed, N. A. Wilson, E. G. Rakasz, D. R. Burton and T. C. Friedrich (2011). "Macaque long-term nonprogressors resist superinfection with multiple CD8+ T cell escape variants of simian immunodeficiency virus." J Virol 85(1): 530-541.

               

Were, E., K. Curran, S. Delany-Moretlwe, E. Nakku-Joloba, N. R. Mugo, J. Kiarie, E. A. Bukusi, C. Celum, J. M. Baeten and H. T. S. T. Partners in Prevention (2011). "A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples." Aids 25(16): 2009-2018.

               

Wilen, C. B., N. F. Parrish, J. M. Pfaff, J. M. Decker, E. A. Henning, H. Haim, J. E. Petersen, J. A. Wojcechowskyj, J. Sodroski, B. F. Haynes, D. C. Montefiori, J. C. Tilton, G. M. Shaw, B. H. Hahn and R. W. Doms (2011). "Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins." J Virol 85(17): 8514-8527.

               

Winstone, N., A. J. Wilson, G. Morrow, C. Boggiano, M. J. Chiuchiolo, M. Lopez, M. Kemelman, A. A. Ginsberg, K. Mullen, J. W. Coleman, C. D. Wu, S. Narpala, I. Ouellette, H. J. Dean, F. Lin, N. Y. Sardesai, H. Cassamasa, D. McBride, B. K. Felber, G. N. Pavlakis, A. Schultz, M. G. Hudgens, C. R. King, T. J. Zamb, C. L. Parks and A. B. McDermott (2011). "Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen." J Virol 85(18): 9578-9587.

               

Wu, X., A. Changela, S. O'Dell, S. D. Schmidt, M. Pancera, Y. Yang, B. Zhang, M. K. Gorny, S. Phogat, J. E. Robinson, L. Stamatatos, S. Zolla-Pazner, P. D. Kwong and J. R. Mascola (2011). "Immunotypes of a quaternary site of HIV-1 vulnerability and their recognition by antibodies." J Virol 85(9): 4578-4585.

               

Wu, X., T. Zhou, J. Zhu, B. Zhang, I. Georgiev, C. Wang, X. Chen, N. S. Longo, M. Louder, K. McKee, S. O'Dell, S. Perfetto, S. D. Schmidt, W. Shi, L. Wu, Y. Yang, Z. Y. Yang, Z. Yang, Z. Zhang, M. Bonsignori, J. A. Crump, S. H. Kapiga, N. E. Sam, B. F. Haynes, M. Simek, D. R. Burton, W. C. Koff, N. A. Doria-Rose, M. Connors, N. C. S. Program, J. C. Mullikin, G. J. Nabel, M. Roederer, L. Shapiro, P. D. Kwong and J. R. Mascola (2011). "Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing." Science 333(6049): 1593-1602.

               

Zembe, L., W. A. Burgers, H. B. Jaspan, L. G. Bekker, H. Bredell, G. Stevens, J. Gilmour, J. H. Cox, P. Fast, P. Hayes, E. Vardas, C. Williamson and C. M. Gray (2011). "Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials." PLoS ONE 6(10): e26096.